While it's certainly true that there are gaps in the current system — especially with respect to expensive, catastrophic drug coverage — and that lower-income Canadians are more likely to suffer as a result, it doesn't mean wiping out the entire market of private sector drug coverage is the best solution.

Previously, Canada could boast about lower business taxes, but Trump's Tax Cuts and Jobs Act abolishes that advantage. So why invest in Canada and pay higher taxes when you can invest next door and pay less?